Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001545:Benserazide / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000096:biosynthesis; D003042:Cocaine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D005133:Eye Movements; D006801:Humans; D007977:Levallorphan / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009021:Morphine Dependence / Q000378:metabolism*; D009043:Motor Activity / Q000187:drug effects; D009297:Nasal Mucosa / Q000378:metabolism; D009638:Norepinephrine / Q000502:physiology; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000502:physiology; D013375:Substance Withdrawal Syndrome
D002395:Catecholamines; D008781:Methyltyrosines; D010879:Piperazines; D012701:Serotonin; D007977:Levallorphan; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D009020:Morphine; D003042:Cocaine; D001058:Apomorphine; D003891:Desipramine; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine